Author

Gary S. Jennings

Biotechnologisches Zentrum

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioinformatics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:protein structure· 1

Frequent Co-Authors

Ben SprangersiD· 1 shared Daniele ParisiiD· 1 shared Jean HermaniD· 1 shared Jörg C. Heinrich· 1 shared Kristien Van BelleiD· 1 shared Melissa F. AdasmeiD· 1 shared Michael SchroederiD· 1 shared Sebastian SalentiniD· 1 shared

Activity by Year

2020-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioinformatics

Ben SprangersORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Structure-based drug repositioning explains ibrutinib as VEGFR2 inhibitor

Melissa F. Adasme, Daniele Parisi, Kristien Van Belle, Sebastian Salentin, V. Joachim Haupt, Gary S. Jennings, Jörg C. Heinrich, Jean Herman, Ben Sprangers, Thierry Louat, Yves Moreau, Michael Schroeder

This paper identifies ibrutinib as a VEGFR2 inhibitor through structure-based drug repositioning, revealing its polypharmacological action beyond BTK.

PLoS ONE · May 27, 2020Peer-reviewedBioinformatics